Expanding installed base, key contracts, and a de-risked platform set the stage for major US growth Cyclopharm (ASX: CYC) has hit a major commercial milestone in the United States, with…
Downer Lands NZ$600 Million Field Services Deal with Powerco
A 12-year agreement reinforces Downer’s dominance in New Zealand’s utilities sector Downer EDI (ASX: DOW) has secured a major win across the Tasman, announcing today it has been awarded a…
Dollarama Strikes Deal to Acquire The Reject Shop in $259m Scheme
Canadian discount giant Dollarama has made its move Down Under, entering into a binding agreement to acquire The Reject Shop (ASX: TRS) in a deal valuing the Aussie retailer at…
Vulcan’s Lionheart Project Gains EU Strategic Project Status Under Critical Raw Materials Act
Vulcan Energy (ASX: VUL) just notched a big win in Europe. Its flagship Lionheart Project has been officially recognised as a Strategic Project under the European Union’s Critical Raw Materials…
KMD Brands Battles Tough Trading, Leans into Direct-to-Consumer Growth
KMD Brands, the parent company of Kathmandu, Rip Curl, and Oboz, has handed down its first-half FY25 results — and it’s a mixed bag. While sales held steady at $470.9…
Clinuvel Reports Promising Stroke Trial Results for PRÉNUMBRA Instant
Clinuvel Pharmaceuticals has shared some encouraging early data from its latest stroke study, with results suggesting its experimental treatment, PRÉNUMBRA Instant, could offer hope to patients who aren’t eligible for…
Immutep Doses First Patient in Landmark Phase III Trial for Lung Cancer
Immutep Limited (ASX: IMM; NASDAQ: IMMP) has officially dosed the first patient in its pivotal Phase III TACTI-004 trial, marking a major milestone in the company’s development of eftilagimod alfa…
James Hardie to Acquire AZEK in US$8.75B Deal, Creating a Building Products Powerhouse
In a bold move to reshape the building products landscape, James Hardie Industries (ASX/NYSE: JHX) has struck a US$8.75 billion deal to acquire US-based AZEK Company Inc. (NYSE: AZEK), forming…
Nanosonics Secures FDA Clearance for CORIS® Infection Prevention System
Nanosonics Limited (ASX: NAN) has hit a major milestone, securing FDA De Novo clearance for CORIS®, its innovative new system designed to enhance infection prevention in hospitals. This approval marks…
Arafura Secures Rare Earths Offtake Deal with Traxys Europe
Arafura Rare Earths (ASX: ARU) has taken another step toward securing its global supply footprint, signing a binding offtake agreement with Traxys Europe SA for NdPr oxide from the Nolans…